Author = Jamal Amri
Dihydroartemisinin Enhances the Therapeutic Efficacy of BH3 Mimetic Inhibitor in Acute Lymphoblastic Leukemia Cells via Inhibition of Mcl-1

Volume 25, Issue 1, January 2024, Pages 325-332

Roya Nazmabadi; Marziyeh Pooladi; Jamal Amri; Yusef Abbasi; Hadi Karami; Marayam Darvish


The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells

Volume 25, Issue 1, January 2024, Pages 343-350

Roya Nazmabadi; Marziyeh Pooladi; Jamal Amri; Marayam Darvish; Yusef Abbasi; Hadi Karami


Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib

Volume 20, Issue 9, September 2019, Pages 2781-2787

Jamal Amri; Neda Molaee; Maryam Baazm; Hadi Karami